Related Experiment Video
Updated: Oct 18, 2025

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
Oncology patients' experiences in experimental medicine cancer trials: a qualitative study
Chelsea Sawyer1, Laurie Preston2, Sally Taylor2,3
1Christie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK chelsea.sawyer@nhs.net.
Objectives:
The study aimed to explore patients' experiences of experimental cancer medicine (ECM) clinical trials.
Design:
The study's design was qualitative. Two focus groups with patients were undertaken followed by semistructured interviews, to explore patients' experiences of ECM clinical trials. Interviews and focus groups were audiorecorded and transcribed verbatim. Data were analysed using thematic analysis.
Setting:
A regional cancer centre (tertiary care) in North-West England.
Participants:
Twelve patients (aged 52-79) participated in one of the two focus groups and 22 patients (aged 42-83) participated in interviews.
Primary Outcome Measure:
Patients' experiences of an ECM trial.
Results:
Four main themes were identified from the analysis: decision making, information needs, the experience of trial participation and impact of trial participation. Subthemes are presented in the manuscript.
Conclusion:
To make fully informed decisions about trial participation, patients required the simplification of trial information and wanted more information about side effects, their response to trial treatment and the overall trial progress throughout the trial. Patients highlighted the need for improvement for the support provided to their family and friends.
Related Concept Videos
Cancer Survival Analysis
Clinical Trials
There are four phases in a clinical trial. A phase one...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Trials: Overview
Treatment Resistant Cancers

